tiprankstipranks
Dr. Reddy's Laboratories Ltd. (IN:DRREDDY)
:DRREDDY
India Market
DRREDDY
Dr. Reddy's Laboratories Ltd.
RESEARCH TOOLSreports

Dr. Reddy's Laboratories Ltd. (DRREDDY) Stock News & Sentiment

10 Followers
Dr. Reddy’s launches India’s first DCGI‑approved generic semaglutide injection Obeda
Premium
Company Announcements
Dr. Reddy’s launches India’s first DCGI‑approved generic semaglutide injection Obeda
23d ago
Dr. Reddy’s clarifies Delhi High Court ruling on semaglutide exports
Premium
Company Announcements
Dr. Reddy’s clarifies Delhi High Court ruling on semaglutide exports
1M ago
Dr. Reddy’s Srikakulam Plant Clears USFDA Inspection With VAI Classification
Premium
Company Announcements
Dr. Reddy’s Srikakulam Plant Clears USFDA Inspection With VAI Classification
1M ago
Dr. Reddy’s Posts Q3 FY26 Earnings Call Transcript for Investors
Premium
Company Announcements
Dr. Reddy’s Posts Q3 FY26 Earnings Call Transcript for Investors
3M ago
Dr. Reddy’s Publishes Audio Recording of Q3 FY2026 Earnings Call
Premium
Company Announcements
Dr. Reddy’s Publishes Audio Recording of Q3 FY2026 Earnings Call
3M ago
Dr. Reddy’s Releases Q3 FY26 Unaudited Results Investor Presentation
Premium
Company Announcements
Dr. Reddy’s Releases Q3 FY26 Unaudited Results Investor Presentation
3M ago
Dr. Reddy’s Gets USFDA Post-Application Action Letter for Hyderabad Biologics Plant
Premium
Company Announcements
Dr. Reddy’s Gets USFDA Post-Application Action Letter for Hyderabad Biologics Plant
3M ago
More IN:DRREDDY News >

DRREDDY News on the Web

Eli Lilly slips, Novo Nordisk holds firm as generic weight-loss drugs flood India
CNBC
Neutral
Inside India newsletter: Tariffs and Iran war threaten India's $100 billion garments export goal
CNBC
Neutral
Inside India newsletter: The worst might not be over for Indian equities
CNBC
Neutral
Inside India newsletter: Ikea has high hopes for the country as it stares at a global slowdown
CNBC
Neutral
India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to stay on top
CNBC
Bullish
Dr. Reddy’s launches India’s first DCGI‑approved generic semaglutide injection Obeda
TipRanks News
Bullish
Strait of Hormuz standoff puts supply of America's generic drug prescriptions at risk
CNBC
Bearish
Dr. Reddy’s clarifies Delhi High Court ruling on semaglutide exports
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
IN:DRREDDY
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.5 articles
News Sentiment
This Week50%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IN:DRREDDY’s Media Buzz Sentiment?
2 articles about IN:DRREDDY were published this week. In an average week, 1.5 articles are published.
    What is IN:DRREDDY’s weekly average amount of articles?
    In an average week, 1.5 articles about IN:DRREDDY are published.
      What is IN:DRREDDY’s News Sentiment?
      50% of articles about IN:DRREDDY were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        STAAStaar Surgical
        IVVDInvivyd
        SLPSimulations Plus
        REPLReplimune Group
        Showing the stocks with the most bullish news sentiment over the past week